NDUFA4L2 was aberrantly expressed in multiple types of cancer, including malignant hepatocellular carcinoma (Lai et al., 2016), colorectal cancer (Lv et al., 2016), ccRCC (Lv et al., 2016). This evidence concerns the gene COXFA4L2 and colorectal cancer.